quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:30:27·86d
INSIDERFiling
Abeona Therapeutics Inc. logo

Director Zeiher Bernhardt G was granted 37,313 shares, increasing direct ownership by 79% to 84,458 units (SEC Form 4)

ABEO· Abeona Therapeutics Inc.
Health Care
Original source

Companies

  • ABEO
    Abeona Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jun 2UpdateOppenheimer$19.00
  • Mar 5UpdateOppenheimer$16.00
  • Jul 3UpdateH.C. Wainwright$15.00
  • May 30UpdateStifel$21.00
  • Nov 30UpdateSVB Leerink$1.00
  • Nov 29UpdateHC Wainwright & Co.$4.00

Related

  • SEC6d
    SEC Form PRE 14A filed by Abeona Therapeutics Inc.
  • INSIDER16d
    SEC Form 4 filed by Goldan Keith A.
  • INSIDER16d
    SEC Form 3 filed by new insider Goldan Keith A.
  • SEC16d
    Abeona Therapeutics Inc. filed SEC Form 8-K: Financial Statements and Exhibits
  • PR16d
    Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors
  • PR17d
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • PR21d
    Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York
  • INSIDER23d
    SEC Form 4 filed by Seshadri Vishwas
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022